NCT07658391Not yet recruiting
Optimizing CBSST With Executive Function Training for Schizophrenia (R33)
Optimizing Cognitive Behavioral Social Skills Training With Executive Function Training for Older Adults With Schizophrenia
Source: ClinicalTrials.gov · Last updated 23 Jun 2026
Brief summary (registry, in English)
This randomized controlled clinical trial will test a blended intervention that combines Executive Function Training with Cognitive-Behavioral Skills Training (E-CBSST). E-CBSST will be delivered to adults with late-life schizophrenia to determine if it increases Cognitive Behavioral Social Skills Training skills learning more than a supportive contact control condition and leads to improved functioning.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 106 (estimated)
- First submitted
- 11 Jun 2026
- Start date
- 1 Oct 2026
- Primary completion date
- Jun 2029
- Lead sponsor
- University of California, San Diego
- Diseases
- Schizophrenia
- NCT number
- NCT07658391
What you commit to
- Study type: Interventional
- Planned participants: 106
- From 1 Oct 2026 to the primary completion date, Jun 2029
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Meets diagnostic criteria for bipolar disorder, current major depressive episode, or substance abuse or dependence within the six months prior to the baseline assessment except for caffeine or nicotine;
- Received electroconvulsive therapy within six months of the baseline assessment.
Other illness
- Meets criteria for a cognitive disorder or for a neurological or other medical disorder affecting the ability to participate in Executive Function Training or CBSST;
Who the study is looking for
- Voluntary informed consent to participate;
- Age 60 years or older;
- DSM-5 diagnosis of schizophrenia or schizoaffective disorder based on the SCID;
- Be clinically stable as operationalized by (1) not having been admitted to a psychiatric hospital within the three months prior to assessment, (2) having had no change in antipsychotic medication dosage within four weeks prior to the baseline assessment, and (3) and ascertained to be clinically and medically stable by one the study investigators;
- Be willing and able to speak English;
- Be able to read and converse (with corrected vision or hearing if needed).
Age in the registry: 60 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UT Southwestern Medical Center Coordinator of this site? Confirm its status | Dallas | United States | Unknown status |
| University of California San Diego Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.